It was a great pleasure to see GenomeWeb features Omixon Target again in a new article in which they describe Vendors are Cautiously Optimistic as Illumina Readies BaseSpace App Store.

Omixon, for instance, is developing an HLA genotyping application for identifying disease associations using whole-genome or whole-exome data as well as from targeted sequencing data, Attila Bérces, the company’s CEO, says. The app, which is currently in beta testing, will also be included in Omixon Target, the company’s desktop software tool for analyzing targeted next-generation sequence data, he adds.